AMRX logo

Amneal Pharmaceuticals (AMRX) Debt to equity ratio

annual debt to equity:

-22.75-156.24(-117.04%)
December 31, 2024

Summary

  • As of today (May 29, 2025), AMRX annual debt to equity ratio is -22.75, with the most recent change of -156.24 (-117.04%) on December 31, 2024.
  • During the last 3 years, AMRX annual debt to equity has fallen by -30.38 (-398.17%).
  • AMRX annual debt to equity is now -117.04% below its all-time high of 133.49, reached on December 31, 2023.

Performance

AMRX Debt to equity Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAMRXfinancial health metrics

quarterly debt to equity:

-18.80+3.95(+17.36%)
March 31, 2025

Summary

  • As of today (May 29, 2025), AMRX quarterly debt to equity ratio is -18.80, with the most recent change of +3.95 (+17.36%) on March 31, 2025.
  • Over the past year, AMRX quarterly debt to equity has increased by +22.51 (+54.49%).
  • AMRX quarterly debt to equity is now -114.08% below its all-time high of 133.49, reached on December 31, 2023.

Performance

AMRX quarterly debt to equity Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAMRXfinancial health metrics

Debt to equity Formula

Debt To Equity =  
Total Debt
Shareholders Equity

AMRX Debt to equity Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-117.0%+54.5%
3 y3 years-398.2%-368.2%
5 y5 years-300.6%-290.7%

AMRX Debt to equity Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-117.0%at low-114.1%+58.6%
5 y5-year-117.0%at low-114.1%+58.6%
alltimeall time-117.0%at low-114.1%+58.6%

AMRX Debt to equity History

DateAnnualQuarterly
Mar 2025
-
-18.80(-17.4%)
Dec 2024
-22.75(-117.0%)
-22.75(-16.1%)
Sep 2024
-
-27.12(-40.4%)
Jun 2024
-
-45.47(+10.1%)
Mar 2024
-
-41.31(-130.9%)
Dec 2023
133.49(+1363.7%)
133.49(+1541.9%)
Sep 2023
-
8.13(-5.6%)
Jun 2023
-
8.61(-7.2%)
Mar 2023
-
9.28(+1.8%)
Dec 2022
9.12(+19.5%)
9.12(-0.9%)
Sep 2022
-
9.20(-7.1%)
Jun 2022
-
9.90(+41.2%)
Mar 2022
-
7.01(-8.1%)
Dec 2021
7.63
7.63(-2.9%)
DateAnnualQuarterly
Sep 2021
-
7.86(-2.4%)
Jun 2021
-
8.05(-6.9%)
Mar 2021
-
8.65(-6.9%)
Dec 2020
9.29(-18.1%)
9.29(-1.0%)
Sep 2020
-
9.38(+1.4%)
Jun 2020
-
9.25(-6.2%)
Mar 2020
-
9.86(-13.1%)
Dec 2019
11.34(+116.0%)
11.34(-6.2%)
Sep 2019
-
12.09(+110.3%)
Jun 2019
-
5.75(+2.7%)
Mar 2019
-
5.60(+6.7%)
Dec 2018
5.25(-240.4%)
5.25(-8.5%)
Sep 2018
-
5.74(+3.6%)
Jun 2018
-
5.54(-248.1%)
Dec 2017
-3.74
-3.74

FAQ

  • What is Amneal Pharmaceuticals annual debt to equity ratio?
  • What is the all time high annual debt to equity for Amneal Pharmaceuticals?
  • What is Amneal Pharmaceuticals annual debt to equity year-on-year change?
  • What is Amneal Pharmaceuticals quarterly debt to equity ratio?
  • What is the all time high quarterly debt to equity for Amneal Pharmaceuticals?
  • What is Amneal Pharmaceuticals quarterly debt to equity year-on-year change?

What is Amneal Pharmaceuticals annual debt to equity ratio?

The current annual debt to equity of AMRX is -22.75

What is the all time high annual debt to equity for Amneal Pharmaceuticals?

Amneal Pharmaceuticals all-time high annual debt to equity ratio is 133.49

What is Amneal Pharmaceuticals annual debt to equity year-on-year change?

Over the past year, AMRX annual debt to equity ratio has changed by -156.24 (-117.04%)

What is Amneal Pharmaceuticals quarterly debt to equity ratio?

The current quarterly debt to equity of AMRX is -18.80

What is the all time high quarterly debt to equity for Amneal Pharmaceuticals?

Amneal Pharmaceuticals all-time high quarterly debt to equity ratio is 133.49

What is Amneal Pharmaceuticals quarterly debt to equity year-on-year change?

Over the past year, AMRX quarterly debt to equity ratio has changed by +22.51 (+54.49%)
On this page